Book Reviews
786 The
Pharmacologic
Principles
Practice, 4th edition, and
C.
Jelleff
Baltimore, The
Carr.
1958,
fourth
by John Williams
pp.
edition
thoroughly
up-to-date
The
better
edition.
book.
unofficial
approach
referencing
to
the
are greatly Where
drug action
out.
Carr
Both
drugs
and
improved
discussed. the
cross-
over the last
the mechanism
so that rational Part
is a
the official
are
and Circulation.”
of
therapy
6, of special
to cardiologists and to circulatory “The Pharmacologic is entitled, the Heart
Wilkins,
interest
physiologists, Response of
The
chapters
of
this part of the text deal with general considerations, digitalis, response
quinidine
of coronary
sion, blood clotting tem.
Each
and procain amide, the
vessels to drugs, hypertenand the hematopoietic
chapter
in this country
The
historical
Fuchs,
Professor
sys-
has a useful list of refer-
ences, chiefly readily available journals published
and books
in the past 10 years.
notes
add
color
of Medicine
to the text.
at Tiibingen
from
1535 to 1566, gave the name Digitalispurpurea the plant
we still use in preparing
His celebrated
treatise
in Base1 in 1542.
Our name for the plant, foxglove, been derived from folksglove, According
to
the drug.
“De historia stirpium com-
mentarii insignis,” was published
that hypertension
in man is usually of psychoso-
matic origin. The coverage of drugs applicable to the treatment of hypertension is fairly thorough,
and
drugs
it is possible,
is stressed,
can be carried
and
Jr.
of Pharmacologic Princa$les
Practice by Krantz
the
Medical
1,313, $14.00.
of Medical and
of
C. Krantz,
the principal
tranquilizing genie the
value especially in neuro-
hypertension.
principal
omission noted being the
drugs-of
The
disadvantage
failure
of many
favorably
certainly
needs explanation.
(page
The principal
so that
to the compound
the hypertensive
patient
with one of these compounds soon ceases to ex perience any lowering of blood pressure after receiving a dose. This textbook of 1,313
pages is weighty
of the pharmaceutical
industry
and of the country’s
in this country
lead in synthesizing This
lead
was
recognized
“Pharmacology August
and
1956.
National
This
Institutes
Involved
in
in
article
for
1956-60”
new
and
Julyby the
entitled “Problems
Plan
Research
states
lags behind capitalist
of covery substances.
U.S.S.R. for
(translated
of Health)
for
new drugs.
the
Toxicology”
Five-Year
Pharmacology U.S.S.R.
and evaluating
that
in the
states in the dis-
effective DAVID
medicinal B.
DILL
A Contribution to the Study of Portal Hypertension by Alan H. Hunt.
cases of portal
written clinical
with the purpose of reviewing material in order to evaluate
of digitalis
and of
derived glycosides is treated thoroughly and the therapeutic applications are described. The by the reference
to the
successful use of quinidine in conjunction with digitalis on the one hand and the emphasis placed on occasional disastrous results from small doses of quinidine in “the heart poisoned by digitalis.” 43, Pharmacologic Agents in Hyperten-
sion, deals incompletely with the factors concerned in the regulation of blood pressure levels. Some cardiologists will not accept the statement
Edinburgh,
Baltimore,
1958
E. & S. Livingstone
personal
Chapter
evi-
dence of the productivity
The
will be puzzled
oc-
treated
Ltd.,
student
dis-
of any of the nitrite group lies in the
To keep her slender fingers from the sun, Pan through the pastures oftentimes has run To pluck the speckled fox-gloves from their stem, And on those fingers neatly placed them.
of action
to 949)
is said to have
i.e., fairies’ glove.
to W. Browne,
mechanism
the
lies in
patients
to this chemical
fact that rapid adaptation curs,
that
nitrite
hypertensive
respond advantage
statement
of sodium
exclusive
U.
(Williams S.
& Wilkins,
agents),
pp.
230?
analyzes
250
$8.50. The
present
newer methods
report,
which
hypertension,
of treatment.
has been the the
The first patient
was seen in 1947 and the last to be included in this series was observed in 1956. The follow-up observations ranged from six months to many years. This study the liver which
indicated develops
that cirrhosis of without known
predisposing cause is likely to be mild, whereas cirrhosis due to a specific cause is more often severe or progressive. However, the prognosis depends upon the severity rather than the THE
AMERICAN
JOURNAL
OF CARDIOLOGY